Urgent support needed: $17 billion to help vaccinate the world


December 14, 2021
Dorothy Monza, Advocacy Associate

 

**The final signed letter, with 81 members of Congress in support, is here. Thank you for your advocacy!**

Throughout the COVID-19 pandemic we have seen what the world can accomplish when we work together. The public and private sector, supported by an influx of government funding, rapidly developed multiple vaccines that can reduce the worst effects of COVID-19 and save lives. Unfortunately, the solidarity we saw in the scientific community has not translated to the equitable distribution of COVID-19 vaccines.

A new bicameral (both House and Senate) letter is circulating calling on the U.S. Congressional Appropriators to direct $17 billion in supplemental funding to this year’s appropriations bills to support American-led efforts to vaccinate the world. This is a small investment in the scheme of things when you consider the lives this would save and the potential future variants of COVID-19 it could prevent.

High-income countries like the U.S. have secured enough vaccines for residents to receive 3 doses for free—meanwhile less than 8 percent of people who live in Africa are fully vaccinated. Whether we look at vaccination rates by geography or income level, the disparity is immense, and growing. Acting now to vaccinate the world is not only the morally correct decision, but the most cost-effective strategy to ending the COVID-19 pandemic once and for all.

Click here to view the final signed letter.

House of Representatives

Allred
Auchincloss
Barragán
Bass
Blumenauer
Bonamici
Bourdeaux
Bowman
Boyle
Carbajal
Casten
Castro
Cicilline
Clarke
Cleaver
Connolly
Correa
Costa
Courtney
Craig
Dean
DeFazio
DeSaulnier
Deutch
Doggett
Espaillat
García
Grijalva
Himes
Horsford
Houlahan
Huffman
Jackson Lee
Jacobs
Jayapal
Jones
Keating
Khanna
Kim
Krishnamoorthi
Lamb
Langevin
Larson
Levin
Lieu
Lofgren
Lynch
Malinowski
Maloney
McGovern
Nadler
Newman
Norton
Ocasio-Cortez
Panetta
Phillips
Plaskett
Raskin
Ross
Schakowsky
Schrier
Sherrill
Sires
Smith
Stevens
Takano
Titus
Tlaib
Tonko
Veasey
Watson Coleman
Welch

Senate

Baldwin
Brown
Markey
Merkley
Sanders
Schatz
Smith
Van Hollen
Warren

 

The Access to COVID-19 Tools Accelerator, or ACT-A, determined it needs $23 billion over the next 12 months for all four of its pillars of COVID response: vaccines, diagnostics, treatments, and health system support. However, this estimate does not include the full cost of last-mile delivery of vaccines. Based on our extensive analysis and its own experience delivering COVID-19 vaccines, CARE estimates that at minimum, it costs $11 to fully vaccinate a person, and the cost is even higher in hard-to-reach contexts. This amounts to approximately an additional $40 billion to reach ACT-A’s targeted population of 3.6 billion people, bringing the total cost to reach 70% vaccination to $63 billion.

Low-and-middle-income countries will likely need donors to cover at least half of the total $40 billion, or $20 billion, needed for delivery costs. The $20 billion for delivery and the $23 billion needed for ACT-A, means donor countries need to step up to give $43 billion to end the pandemic for us all. Using the OECD-DAC recommended formula, the U.S. fair share of this contribution is $17 billion.

JOIN US

Stay Connected

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.